TRIDENT LIFELINE LIMITED's most recent trade in Trident Texofab Ltd. was a Acquisition of 3,000 Equity Shares done at an average price of Rs. 170.6 . Disclosure was reported to the exchange on March 29, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for TRIDENT LIFELINE LIMITED in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trident Texofab | TRIDENT LIFELINE LIMITED | Promoter Group | Acquisition | 29 Mar 2025 | 3,000 | 35,000 (0.25%) | 0.03% | 170.6 | 511,708 | 28 Mar 2025 28 Mar 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Trident Texofab | TRIDENT LIFELINE LIMITED | Promoter Group | Acquisition | 28 Mar 2024 | 22,000 | 32,000 (0.32%) | 0.22% | 49.0 | 1,076,902 | 27 Mar 2024 27 Mar 2024 |
Insider Trading | Equity Shares | Market Purchase |
| Trident Texofab | TRIDENT LIFELINE LIMITED | Promoter Group | Acquisition | 06 Sep 2023 | 10,000 | 10,000 (0.10%) | 0.10% | 63.8 | 638,348 | 05 Sep 2023 05 Sep 2023 |
Insider Trading | Equity Shares | Market Purchase |